A Phase I Study of a Novel Tracer for Positron Emission Tomography "PET" Myocardial Perfusion Imaging "MPI"
Lead SponsorSynektik S.A.
StatusCompleted No Results Posted
Indication/ConditionCoronary Artery Disease
[11C]-dimethyl-diphenyl ammonium ([11C]-DMDPA) - A Phase I, Open-label, Safety and Tolerability, Radiation Dosimetry, Biodistribution, First-in-Human Study of a Novel 11C-labeled Tracer for Positron Emission Tomography Myocardial Perfusion Imaging
A single Intravenous bolus injection of 11C[DMDPA]
Inclusion Criteria: body mass index (BMI) between 18.0 and 30.0 kg/m2 good health written informed consent Exclusion Criteria: smokers subject receiving medication a blood transfusion in the 4 weeks prior to screening positive alcohol blood test Subjects who suffer from claustrophobia Subjects who have had a clinically significant illness Subjects exposed to radiation within 12 months prior to screening